Tune Therapeutics

Tune's Co-Founder, President, and CFO Akira Matsuno explains the science of epigenetic editing and Tune’s mission to target common and chronic diseases at the 2024 Breakthrough West Summit hosted by STAT and moderated by Allison DeAngelis. #TuneTx #STATBreakthrough

Wishing a happy birthday to Gregor Mendel. His pioneering work on pea plant genetics laid the foundation for our transformative genetic tuning therapies. To celebrate, enjoy this paper that explores the role the epigenome may play in pigeon pea plant flowering! https://bit.ly/4ezVBhM #Genetics #Epigenetics #GregorMendel

Genetic tuning not only provides exquisite target specificity, but it also rules out the possibility of off-target DNA damage and repair responses – because no damage is done, and no repair is necessary. And critically, because genetic tuning does not create strand breaks in DNA, it is far better suited to working with multiple genes at once (or multiplexing) when compared to other gene therapy modalities. Armed with this technology, we can confidently target not just single genes but multiple nodes of control within a complex gene network. This expands the scope of genetic tuning to complex diseases involving the interaction of multiple genes and cell types, which describe the vast majority of common and chronic diseases we face today. Explore more: https://bit.ly/4eYtdpX #GeneticTuning #Epigenome #TuneTx

Genetic tuning is a unique modality of genetic medicine enabled by cutting-edge advances in gene regulation. The resultant technology enables exquisite levels of control over gene activity – activating, silencing, or fine-tuning the output of specific genes to reverse cellular dysfunction and disease. Let’s explore the science behind genetic tuning and how it will change the game when it comes to the treatment of common and chronic diseases. #GeneticTuning #Epigenetics #TuneTx

Brian Cosgrove, Principal Scientist at Tune Therapeutics recently sat down with Harsh Thakkar on the Life Sciences 360 podcast to discuss epigenetic editing and the exciting progress of our HBV program. Tune in below: YouTube- https://bit.ly/3VUHbQJ Apple- https://apple.co/3RXPoS1 Spotify- https://spoti.fi/3EbDZbr Amazon- https://amzn.to/3K5gpRv #TuneTx #EpigeneticEditing #HBV #LifeSciences #Podcast #LifeSciences360

Sara Che, PhD, Senior Scientist at Tune is heading to Hamburg, Germany, to present next week at #ISSCR2024 as part of the symposium, "Frontiers in Epigenomic Control for Enhanced Stem Cell Therapies." Her presentation will focus on the exciting progress being made in manipulating the epigenome to direct stem cell fate and function. See the full schedule: https://bit.ly/3zgrLPf #ISSCR #RegenerativeMedicine

In case you missed it, Derek Jantz, Chief Scientific Officer at Tune Therapeutics, discussed genetic tuning as the next frontier of genetic medicine in this enthralling article from Technology Networks. Dive into the article to learn how genetic medicine is getting a major tune-up with genetic tuning. https://bit.ly/45o9Amy #GeneticTuning #Epigenetics #TuneTx

Building a strong team, in turn, builds a strong company. Tune's Co-Founder, President, and CFO Akira Matsuno recently shared his perspective at the STAT 2024 Breakthrough West Summit on the three crucial components of building a successful biotech startup. #TuneTx #STATBreakthrough

Emerging technologies like gene editing and cellular reprogramming offer promising avenues for more dynamic control over aging and health. Dr William Greene on Impact Theory podcast with Tom Bilyeu. Watch the full episode here ▶️ https://lnkd.in/dQj-HFig   #healthtech #medtech #biotechnology #bioeconomy #venturecapital #innovation

Did you know that there are epigenetic changes associated with Alzheimer's disease? There is a growing body of evidence to suggest epigenetic changes play a pivotal role in the pathogenesis of this devastating neurodegenerative disorder. See this review article to learn more about the interplay between epigenetic alterations and Alzheimer's disease: https://bit.ly/4bZc7pZ #AlzheimersAndBrainAwarenessMonth #Alzheimers #Epigenetics